Remus Pharmaceuticals L

NSE: REMUS · Other · sector

₹892.30NSE close 2026-10-26

Key numbers

Market cap₹680 cr

Price₹892.30

52w high / low₹1,039 / ₹580

P/E22.8xSector median 14.4x

P/B1.9xSector median 1.7x

Book value₹460.8

Dividend yield0.17%Sector median 0.37%

ROE12.2%Sector median 13.8%

ROCE16.2%Sector median 19.6%

OPM6.6%Sector median 10.4%

Debt / equity0.07xSector median 0.29x

EV/EBITDA11.9xSector median 8.4x

Interest cover41.2x

Current ratio1.98x

Sales growth 3y+166.6%Sector median +7.7%

Profit growth 3y+63.2%Sector median +16.6%

PEG–

Last 12 months to Mar 2026, Consolidated. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹30 cr vs borrowings ₹23 cr (FY26): cash is higher (net cash).
Operating profit covered interest 41.2x in the last 12 months.
Operating cash flow was below net profit in 4 of the last 4 years (FY26, FY25, FY24, FY23).
Other income was 18% of net profit in the last 12 months.
No dividend in the last 4 financial years.
Price ₹892.30 on 2026-10-26: -14.1% from the 52-week high, +53.8% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹2,723.20 · low ₹582.85

Quarterly results

₹ cr	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Revenue	25	29	183	273	348	400	453
EBITDA	6	9	21	21	25	27	30
OPM %	23.4%	31.9%	11.3%	7.5%	7.1%	6.7%	6.6%
Other income	1	2	4	3	3	3	4
Net profit	4	6	16	14	16	18	19
EPS (₹)	42.49	41.51	110.50	23.78	34.92	18.33	20.86
Revenue YoY					+1,316.5%	+1,278.1%	+147.2%
Profit YoY					+261.4%	+209.7%	+22.7%

Consolidated figures where filed. Latest quarter Mar 2026.

Profit & loss (yearly)

₹ cr	FY23	FY24	FY25	FY26	TTM
Revenue	45	212	620	854	854
EBITDA	11	28	46	57	57
Net profit	8	22	29	37	37
EPS (₹)	83.24	152.01	65.21	39.19	39.19
Revenue growth		+371.9%	+191.9%	+37.6%	–
Profit growth		+153.4%	+35.0%	+27.2%	–
Dividend / share (₹)	–	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	+166.6%	–	–
Net profit	+63.2%	–	–
EPS	-22.2%	–	–
Share price	–	-15.9% (2y)	+32.5%

Balance sheet

₹ cr	FY23	FY24	FY25	FY26
Shareholders' equity	–	–	256	351
Borrowings	–	–	21	23
Cash & equivalents	–	–	8	30
Total assets	–	–	433	579
Fixed assets	–	–	7	6
Capital work in progress	–	–	0	8
Investments	–	–	186	257
Receivables	–	–	108	140
Inventory	–	–	52	72
Payables	–	–	71	76

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY23	FY24	FY25	FY26
Cash from operations	5	4	7	18
Cash from investing	-15	-9	-11	-15
Cash from financing	12	24	6	1
Capex	0	0	4	15
Free cash flow	5	4	3	4

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY23	FY24	FY25	FY26
ROE %	–	–	11.4%	10.5%
ROCE %	–	–	17.6%	16.2%
Debtor days	–	–	64	60
Inventory days	–	–	35	35
Payable days	–	–	49	37
Cash conversion cycle (days)	–	–	50	58
Working capital days	–	–	59	62

Peers in Other

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
TSFINV	₹8,585 cr	17.6x	1.4x	8.4%	3.6%	20.5%	+121.7%	2.30%
KRISHANA	₹6,339 cr	39.9x	11.3x	41.6%	23.2%	12.6%	+95.7%	0.05%
MARINE	₹5,431 cr	84.2x	11.0x	14.3%	18.0%	10.8%	+25.6%	0.07%
ZOTA	₹4,139 cr	–	6.0x	-22.5%	-12.4%	-0.5%	+56.7%	0.07%
AIMTRON	₹3,319 cr	71.7x	17.1x	28.0%	31.8%	21.8%	–	–
ACCORD	₹2,984 cr	–	261.7x	12.4%	12.0%	2.4%	–	–
MONOLITH	₹2,646 cr	64.6x	24.3x	36.0%	48.7%	24.4%	–	–
UTSSAV	₹2,390 cr	40.2x	14.1x	43.4%	54.7%	7.9%	–	–
BETA	₹2,200 cr	40.6x	5.0x	16.4%	17.0%	20.8%	–	–
REMUS	₹680 cr	22.8x	1.9x	12.2%	16.2%	6.6%	+166.6%	0.17%

All 688 companies in Other →

Documents

Links go to the original files on the exchange website.

About the company


Sector
Industry	Other
Sub-industry
Symbol	REMUS
BSE code	–
ISIN	INE0O5T01011
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results); price = NSE close 2026-10-26.